REGN · Forms 3, 4, 5
Insider trades at REGENERON PHARMACEUTICALS, INC.
1 insider sold $3.2M of REGENERON PHARMACEUTICALS, INC. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for REGENERON PHARMACEUTICALS, INC. (REGN) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 6 | $753.76 | $5K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 35 | $755.91 | $26K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 16 | $757.68 | $12K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 24 | $758.16 | $18K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 14 | $759.96 | $11K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 74 | $760.65 | $56K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 27 | $761.36 | $21K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 55 | $762.57 | $42K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 25 | $763.76 | $19K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 219 | $764.40 | $167K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 271 | $765.39 | $207K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 279 | $766.47 | $214K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 192 | $767.39 | $147K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 105 | $768.33 | $81K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 127 | $769.30 | $98K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 12 | $770.20 | $9K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 283 | $771.56 | $218K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 211 | $772.56 | $163K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 224 | $773.40 | $173K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 121 | $774.48 | $94K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 376 | $775.46 | $292K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 66 | $776.31 | $51K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 38 | $777.76 | $30K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 454 | $778.64 | $354K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 380 | $779.59 | $296K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 463 | $780.63 | $361K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Sell | 50 | $781.47 | $39K | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Option exercise | 17,000 | $381.92 | $6.5M | Form 4 | |
| Andrew J Murphy | Co-Chief Scientific Officer | Tax withholding | 12,853 | $754.58 | $9.7M | Form 4 | |
| Marion McCourt | EVP Commercial | Sell | 1,131 | $857.39 | $970K | Form 4 | |
| Marion McCourt | EVP Commercial | Sell | 1,215 | $850.00 | $1M | Form 4 | |
| Kathryn Guarini | Director | Option exercise | 400 | $719.37 | $288K | Form 4 | |
| Kathryn Guarini | Director | Sell | 400 | $850.00 | $340K | Form 4 | |
| Joseph J Larosa | EVP General Counsel and Secret | Option exercise | 12,282 | $381.92 | $4.7M | Form 4 | |
| Joseph J Larosa | EVP General Counsel and Secret | Tax withholding | 9,019 | $830.15 | $7.5M | Form 4 | |
| Christopher R. Fenimore | EVP Finance CFO | Option exercise | 6,283 | $381.92 | $2.4M | Form 4 | |
| Christopher R. Fenimore | EVP Finance CFO | Tax withholding | 4,599 | $813.47 | $3.7M | Form 4 | |
| Kathryn Guarini | Director | Option exercise | 400 | $719.37 | $288K | Form 4 | |
| Kathryn Guarini | Director | Sell | 400 | $800.00 | $320K | Form 4 | |
| Huda Y Zoghbi | Director | Option exercise | 800 | $376.69 | $301K | Form 4 | |
| Huda Y Zoghbi | Director | Sell | 800 | $800.00 | $640K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.